Home › Acute Lymphoblastic Leukemia › NCT06074666

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Who can join

Ages 3 to 9 · All sexes

Inclusion Criteria:

* Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
* Parent has primary medication responsibility.
* Pediatric patient aged 3-9 years
* Child on therapy that includes home-based oral anti-cancer medication, such as 6-MP.
* Parent has verbal English or Spanish fluency.
* Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure

Exclusion Criteria:

* Parent is unwilling or unable to follow protocol requirements

About the study

The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.

What is being tested

• CareMeds Intervention (behavioral)
• Usual Care Group (behavioral)

Sponsor: Roswell Park Cancer Institute · Participants: 100 · Started: Nov 7, 2024

Contact the study team

• Elizabeth Bouchard, PhD · Phone: 716-845-1300

Official record on ClinicalTrials.gov — NCT06074666

Locations in the U.S.

Conditions

• Acute Lymphoblastic Leukemia

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.